Breadcrumb Home Stories News and Updates General News Releases FDA Approval of Epidiolex for Lennox-Gastaut Syndrome and Dravet Syndrome Statement from Dr. Anne Comi, Director of the Hunter Nelson Sturge-Weber Center, Kennedy Krieger Institute Read More Kennedy Krieger Institute Announces Retirement of President and CEO The Institute’s board of directors is conducting a national search and is expected to name a new CEO in the coming months. Read More Pagination Previous page ‹ Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Current page 7
FDA Approval of Epidiolex for Lennox-Gastaut Syndrome and Dravet Syndrome Statement from Dr. Anne Comi, Director of the Hunter Nelson Sturge-Weber Center, Kennedy Krieger Institute Read More
Kennedy Krieger Institute Announces Retirement of President and CEO The Institute’s board of directors is conducting a national search and is expected to name a new CEO in the coming months. Read More